Benvitimod, also known as tapinarof, is a non-steroidal, topical aryl hydrocarbon receptor-modulating agent used for the treatment of plaque psoriasis. To ensure rigorous quality control and regulatory… Read more


































Benvitimod, also known as tapinarof, is a non-steroidal, topical aryl hydrocarbon receptor-modulating agent used for the treatment of plaque psoriasis. To ensure rigorous quality control and regulatory compliance, pharmaceutical laboratories require high-quality analytical standards to monitor drug integrity and performance. This category contains a comprehensive selection of reference standards, including the active pharmaceutical ingredient, its known process impurities, and synthetic degradation products such as the cis-isomer. These compounds are essential tools for impurity profiling, allowing researchers to identify and quantify potential contaminants during method development and validation. Furthermore, the inclusion of stable isotope labelled compounds, such as deuterated variants, facilitates accurate mass spectrometry-based analysis and pharmacokinetic studies. By utilizing these specialized reference materials, analysts can confirm the safety, efficacy, and consistency of benvitimod formulations throughout the manufacturing process.